WOODBURN, Ore.--(BUSINESS WIRE)--Socati Corp today announced the ability to customize cannabinoid profiles for its hemp-derived ingredients, enabled by the company’s patented chromatographic-based technology. The first customized ingredient products based on this technology were announced at the same time -- each with a broad-spectrum profile featuring a minimum of 80 percent cannabidiol (CBD) and four percent of the minor cannabinoid cannabigerol (CBG).
The two products, an oil ingredient known as Socati CBG NDT and a water-soluble version called Socati Soluble are made possible by Socati’s advanced chromatographic technology that allows the company to target and separate minor cannabinoids and then create fully customized cannabinoid profiles for consumer packaged goods (CPG) manufacturers. Because of this technology, Socati is able to create custom blends that consistently hit a manufacturer’s exact specifications for the levels of each cannabinoid.
“Consumers are demanding increasingly personalized products, and manufacturers are looking for ways to respond to that demand,” said Socati CEO, Josh Epstein. “Socati’s proprietary technology creates hemp extracts that behave just like any other food ingredient, allowing CPG manufacturers address these demands.”
At launch, both products offer high levels of CBD and CBG, with non-detectable THC levels - far lower than industry standards. While CBD has become the best known of the non-psychoactive cannabinoids in recent years, a host of other compounds exist in hemp that show strong promise for those looking to promote health and wellness. Like CBD, CBG is a compound that shows exciting potential to benefit health.
In addition to its new custom cannabinoid profile offerings, the company will, in the coming months, offer additional ingredient products featuring customizable levels of other minor cannabinoids including cannabinol (CBN) and cannabichromene (CBC).
More than 100 unique compounds called cannabinoids are found in hemp. Though most people are familiar with major cannabinoids like CBD and THC, many of these compounds – including CBG – appear in far lower levels in the plant. As consumers learn more about the properties of specific cannabinoids, they are asking for products and varieties that address their individual needs.
“Hemp-derived cannabinoids show tremendous potential to help consumers in myriad ways,” Epstein added. “Producing ingredients that meet the standards for quality, purity, and customization that manufacturers have come to expect from all their ingredient providers will help unleash that potential.”
Backed by extensive internal and third-party analytical testing, Socati’s Montana-based processing facility complies with Global Food Safety Initiative (GFSI)-recognized benchmarking requirements and adheres to Good Manufacturing Practice (GMP) standards for manufacturing.
This announcement is the latest in a series of major developments for Socati, including raising more than $40 million in private capital, the addition of experienced corporate leaders to its board of directors and the acquisition of Blue Marble, a Montana-based, food quality processing facility.
Socati is a leading processor of broad-spectrum hemp extracts. The company provides a top-quality and consistent product for a market projected to reach $22 billion by 2022. Leveraging investments in new technologies, Socati engages in large-scale manufacturing and has logistics in place to process increasing amounts of hemp biomass to meet demand. With the ability to manufacture broad-spectrum hemp extracts at scale, Socati is built to serve the needs of large, international CPG companies that are seeking high-quality raw materials. To learn more about Socati, visit www.socati.com.